Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 03, 2021

SELL
$14.9 - $20.82 $252,555 - $352,899
-16,950 Closed
0 $0
Q1 2021

May 04, 2021

SELL
$12.57 - $21.22 $4,148 - $7,002
-330 Reduced 1.91%
16,950 $360,000
Q4 2020

Feb 01, 2021

SELL
$8.73 - $14.56 $9,341 - $15,579
-1,070 Reduced 5.83%
17,280 $228,000
Q2 2020

Aug 07, 2020

SELL
$6.63 - $12.85 $509,595 - $987,676
-76,862 Reduced 80.73%
18,350 $183,000
Q1 2020

May 04, 2020

BUY
$6.94 - $14.42 $638,639 - $1.33 Million
92,023 Added 2885.64%
95,212 $699,000
Q4 2019

Feb 04, 2020

SELL
$6.23 - $7.98 $186 - $239
-30 Reduced 0.93%
3,189 $27,000
Q3 2019

Nov 12, 2019

BUY
$5.62 - $7.86 $18,090 - $25,301
3,219 New
3,219 $22,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $43.1M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.